ACUTE MYELOBLASTIC LEUKEMIA
Clinical trials for ACUTE MYELOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE MYELOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could early antibiotic stop be safe for kids with cancer?
Disease control Not yet recruitingThis trial looks at whether children with cancer who develop a fever and low white blood cells can safely stop antibiotics earlier than usual. About 136 children will be randomly assigned to either stop antibiotics within 24 hours or continue standard treatment. The goal is to se…
Matched conditions: ACUTE MYELOBLASTIC LEUKEMIA
Phase: PHASE4 • Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Could one antibiotic replace two for chemo fevers? major trial launches
Disease control Not yet recruitingThis study compares a single antibiotic (amoxicillin-clavulanate) against the standard two-drug combination (amoxicillin-clavulanate plus ciprofloxacin) for treating fever caused by chemotherapy in adults with certain blood cancers. The goal is to see if the simpler treatment wor…
Matched conditions: ACUTE MYELOBLASTIC LEUKEMIA
Phase: PHASE3 • Sponsor: Versailles Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New study aims to predict bleeding and clotting risks in cancer patients
Knowledge-focused Not yet recruitingThis observational study will measure how well the body breaks down blood clots in 150 cancer patients (with blood cancers or solid tumors) who also have clotting issues. Researchers will take extra blood samples during routine care to look for markers that might predict bleeding…
Matched conditions: ACUTE MYELOBLASTIC LEUKEMIA
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC